CTI BioPharma
CTIC
#5850
Rank
C$1.71 B
Marketcap
C$13.03
Share price
0.00%
Change (1 day)
33.48%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): C-$0.77

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is C-$0.83. In 2022 the company made an earnings per share (EPS) of C-$1.22 an increase over its 2021 EPS that were of C-$1.55.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.77-36.4%
2022C-$1.22-21.3%
2021C-$1.5545.95%
2020C-$1.067.25%
2019C-$0.9930.19%
2018C-$0.76-58.91%
2017C-$1.85-29.12%
2016C-$2.61-72.84%
2015C-$9.606.35%
2014C-$9.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.52-1,005.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$44.27-5,426.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.91-3,096.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.02 143.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$3.01-462.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-879.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.64-177.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel